Relapses and treatment status in elderly and non-elderly patients with eosinophilic granulomatosis with polyangiitis

A retrospective observational study using Japanese nationwide claims data

Taniguchi, Masami
Koike, Haruki
Oka, Hayato
Ono, Keita
Sumi, Kazuya
Kato, Yuki
Arita, Yoshifumi
Fujiwara, Masakazu
Makita, Naoyuki
Amano, Koichi

Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Kanagawa, Japan
Division of Neurology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan
AstraZeneca K.K., Osaka, Japan
AstraZeneca K.K., Osaka, Japan
AstraZeneca K.K., Osaka, Japan
AstraZeneca K.K., Osaka, Japan
AstraZeneca K.K., Osaka, Japan
AstraZeneca K.K., Osaka, Japan
AstraZeneca K.K., Osaka, Japan
Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan

Corresponding author: Masami Taniguchi, Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, 18-1 Sakuradai, Minami-ku, Sagamihara, Kanagawa 252-0392, Japan Email: [email protected]

Received October 17, 2024

Received in revised form February 25, 2025

Accepted March 18, 2025

Modern Rheumatology Publish Ahead of Print, March 18, 2025. | DOI: 10.1093/mr/roaf026